Cells4Life, the experts in stem cell processing., Burgess Hill

Cells4Life is a prominent and pioneering company that specialises in the preservation and storage of stem cells, particularly cord blood stem cells, which have garnered significant attention for their potential medical applications. Established with the vision of advancing medical breakthroughs and contributing to the health and well-being of individuals, Cells4Life has emerged as a leader in the field of stem cell banking.


At the core of Cells4Life's mission is the concept of preserving and harnessing the regenerative power of stem cells found in cord blood. Cord blood is the blood that remains in the umbilical cord and placenta after childbirth. This blood is a rich source of hematopoietic stem cells, which have the remarkable ability to differentiate into various types of blood cells and immune system components. These stem cells have been used for decades in treating a range of disorders, such as leukaemia and other blood-related diseases, through stem cell transplants.


Cells4Life recognises the vast potential of cord blood stem cells beyond traditional applications. The company utilises cutting-edge technology to isolate, process, and store these valuable stem cells, ensuring their viability for extended periods. By offering families the opportunity to preserve their new-born's cord blood, Cells4Life empowers them to potentially access personalised regenerative therapies in the future, especially as medical research continues to unveil new avenues for stem cell utilisation.


Cells4Life is committed to giving customers the most stem cells possible from their samples. Found to be the highest performing cord blood processing system when tested in a published, peer-reviewed head-to-head study, TotiCyte delivers 2.2 to 3 times more stem cells at the point of therapy than other leading technologies currently available in the UK. TotiCyte has transformed cell retention both during processing and cryopreservation and is exclusive to Cells4Life.

With its unparalleled commitment to advancing the field of cellular storage, the company has managed to amass an impressive repository of stem cells. These stored cells ensure that families have a greater chance of finding suitable matches for transplantation and therapy, enhancing the effectiveness of these life-saving treatments.

In addition to its focus on cord blood banking, Cells4Life has also diversified its services to encompass the storage of other valuable biological materials, such as cord tissue, placenta tissue, and amniotic tissue. Mesenchymal stem cells, as found in umbilical cord tissue, possess the potential to differentiate into various tissues, including nerve, bone, and cartilage. The umbilical cord has a rich population of mesenchymal stem cells that can contribute to regenerative medicine applications.


To date, Cells4Life have already released 18 samples for treatment, they are an experienced stem cell storage company which successfully prepares samples for therapy. The company released samples for cerebral palsy, autism, stroke, diamond blackfan anaemia, blood disorders like leukaemia, and brain injuries. In 2014, Cells4Life became the first cord blood bank to release a cord tissue sample for an experimental treatment. They are also the only stem cell bank in the UK to offer placenta storage.


Cells4Life is committed to keeping its clients informed about the latest advancements in stem cell research and potential therapeutic breakthroughs, empowering families to make informed decisions about their stored samples.


Standing at the forefront of stem cell banking, Cells4Life is driving innovation in the preservation of cord blood stem cells. Through their unwavering commitment to quality, ethics, and education, the company has positioned itself as a leader in the field, offering families the opportunity to invest in their future health.